Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $54.47M.
ENTERPRISE VALUE (EV)
$54.47M
Oncolytics Biotech Inc.
Market Cap
$59.66M
Enterprise Value (EV)
$54.47M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Oncolytics Biotech Inc. (ONCY) | $59.66M | $54.47M |
| PDS Biotechnology Corporation (PDSB)vs › | $60.39M | $59.16M |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.81M | $50.00M |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | $72.16M |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.78M | $34.36M |
| Adicet Bio, Inc. (ACET)vs › | $60.95M | $40.67M |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.34M | $19.56M |
| Boundless Bio, Inc. (BOLD)vs › | $57.65M | $37.43M |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | $42.38M |
| InterCure Ltd. (INCR)vs › | $63.02M | $105.87M |
Market Cap
$59.66M
Total Debt
$0.00
Cash
$5.20M
Enterprise Value
$54.47M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
